Skip to main content
×

GE.com has been updated to serve our three go-forward companies.

Please visit these standalone sites for more information

GE Aerospace | GE Vernova | GE HealthCare 

Press Release

Nexcelle is Selected to Provide the Nacelle System for the New GE TechX Engine on the *Bombardier Global 7000 and 8000 Business Jet Aircraft

October 18, 2010

CINCINNATI--(BUSINESS WIRE)--Nexcelle will provide the nacelle and thrust reverser for GE's TechX integrated powerplant that has been selected to power the new Bombardier Global 7000 and 8000 business jet aircraft, marking the second major program win for this international joint venture company


business unit
tags
Press Release

Supporting Global Growth in Power Generation, GE Inaugurates New Wind Generator Manufacturing Facility in Vietnam

October 15, 2010

Global manufacturing footprint a strategic growth driver as GE expands in developing markets

Hai Phong, Vietnam ---October 15, 2010 --- Responding to the growing global demand for power generation equipment to support cleaner energy production, GE today inaugurated its first manufacturing facility in Vietnam. The plant opening is the latest in a series of recent moves by GE to further reinforce its position as a worldwide leader in the energy industry.


business unit
tags
Press Release

New GE Solution Connects Doctors to Charts, Each Other

October 15, 2010

Capital Region Healthcare and Decatur Memorial are First Two Test Installs for New Interoperability Feature

BARRINGTON, Ill. -- Oct 14, 2010 -- GE Healthcare has successfully linked its electronic medical records (EMR) solution with several non-GE inpatient systems, providing a single view of the patient record that will go beyond the requirements of meaningful use. The interoperability solution is set to debut at beta sites Capital Region Healthcare (N.H,) and Decatur Memorial Hospital (Ill.) in early 2011 with general availability expected later that year.


business unit
tags
Press Release

Una collaborazione GE e General Dynamics C4 Systems ottimizza l'efficacia e la sicurezza dell'esercito degli Stati Uniti

October 11, 2010

Una collaborazione GE e General Dynamics C4 Systems ottimizza l'efficacia e la sicurezza dell'esercito degli Stati Uniti


business unit
tags
Press Release

GE Healthcare Introduces Advancements to Industry's First Hybrid SPECT/CT Platform

October 11, 2010
Press Release

GE Healthcare Helps Clinicians Understand Disease from the Beginning at European Society of Nuclear Medicine

October 11, 2010
Press Release

GEヘルスケア・ジャパン、国内開発・製造のMRI「Brivo MR355」が、千葉・習志野第一病院で世界初稼働

October 07, 2010

GEヘルスケアグループの日本法人であるGEヘルスケア・ジャパン株式会社(本社:東京都日野市、代表取締役社長:熊谷昭彦)の最新磁気共鳴断層撮影装置(MRI)「Brivo MR355(ブリボー・エムアール・サンゴーゴー)」のグローバル1号機がこのほど、社会医療法人社団 菊田会 習志野第一病院(所在地:千葉県習志野市、院長:三橋稔)で稼働を開始しました。
習志野第一病院で初稼働を始めたBrivo MR355は、当社が開発・製造し、2005年12月の発売以来、既に全世界で550台以上と当社製MRIの中で最速の受注を続けている「Signa HDe(シグナ・エイチディーイー)」シリーズの後継機種。日本のMR技術チームが中心となり、国内医療機関の多様化するニーズに応えるためにBrivoブランド*1として開発し、本年4月に発売した1.5T(テスラ)装置です。


business unit
tags
Press Release

Completion of the Southwestern Ontario Diagnostic Imaging Network Leverages GE Healthcare Technology

October 07, 2010

GE Provides Technological Backbone for Vendor Neutral, Pan-regional Diagnostic Imaging Repository


business unit
tags
Press Release

GEヘルスケア・ジャパン、外科用デジタルCアーム装置「Brivo OEC 850」を発売

October 07, 2010

- 画質と線量の最適バランスと高い操作性を実現、高齢者の低侵襲整形外科治療を支援 -

GEヘルスケアグループの日本法人であるGEヘルスケア・ジャパン株式会社(本社:東京都日野市、代表取締役社長:熊谷昭彦)は10月7日(木)、外科用デジタルCアーム装置(デジタル・モバイル・サージカル・イメージング装置)「Brivo OEC 850(ブリボー・オーイーシー850)」を発売します。

Brivo OEC 850は、米ゼネラル・エレクトリック(GE)が昨年5月に立ち上げた医療戦略「ヘルシーマジネーション*1」をもとに開発され、先ごろ第三者機関によるヘルシーマジネーション認証を獲得した初のOECシリーズの装置。最大の特長は、透視画像の画質とX線照射量を的確にバランスさせる新機能の搭載で、高画質撮像と低被ばくを両立させるとともに、整形外科での臨床使用に最適な操作性を実現したことです。


business unit
tags
Press Release

GE Healthcare Launches Human Cardiomyocytes for Predictive Toxicity Testing

October 06, 2010

Enabling improved accuracy in drug safety through better toxicology testing

Chalfont St.Giles, October 5th, 2010 -- GE Healthcare, a unit of General Electric Company (NYSE: GE), announces the availability of human cardiomyocytes, or heart muscle cells, that provide a more readily available and biologically-relevant alternative to current cell models and primary cells used in drug discovery and predictive toxicity testing.


business unit
tags
Subscribe to Technology Infrastructure